In this episode of The Psychedelic Podcast, Paul F. Austin welcomes Stephanie Karzon Abrams, a neuropharmacologist and founding advisor of Beyond Consulting. With her unique background spanning clinical pharmacology, corporate healthcare, and the music industry, Stephanie shares insights on the intersection of psychedelic science, integrative medicine, and community building. She discusses the transformative potential of psychedelics from a neuropharmacological perspective, her work supporting ketamine clinics and plant medicine brands, as well as her journey from traditional healthcare to pioneering innovative approaches in the psychedelic space.
Stephanie Karzon Abrams, a neuropharmacologist with a Masters of Science in Clinical Pharmacology, is the founding advisor of Beyond Consulting, providing science, research, operations, and strategy solutions to organizations in the natural product, plant medicine, and psychedelic sectors. Her career spans from clinical research and Johnson & Johnson to pioneering innovative healthcare approaches.
Beyond her scientific work, she co-creates community initiatives including Public Secret music label and Mt. Mushmore educational dinner series. As a prescriber for MDMA and psilocybin therapy through Canada's Special Access Program and scientific advisor for the Microdosing Collective, she champions the integration of cutting-edge therapeutic approaches with traditional healthcare. Her work focuses on bridging scientific expertise with strategic thinking to advance innovative healthcare solutions.
These show links may contain affiliate links. Third Wave receives a small percentage of the product price if you purchase through the above affiliate links.
This episode is brought to you by The Practitioner Certification Program by Third Wave’s Psychedelic Coaching Institute. To learn more about our flagship 10-month training program for coaches who want to integrate psychedelic modalities into their practice, click here.